1 |
Fentem A, Riordan R, Doroshenko C, Li X, Kasson E, Banks D, Winograd RP, Cavazos-Rehg P. Impact of the COVID-19 pandemic on burnout and perceived workplace quality among addiction treatment providers. Addict Sci Clin Pract 2023;18:5. [PMID: 36670445 DOI: 10.1186/s13722-023-00361-6] [Reference Citation Analysis]
|
2 |
Meshberg-Cohen S, Farook M, Gross G, Levina V, DeViva J. Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic. Am J Addict 2023;32:32-9. [PMID: 36286598 DOI: 10.1111/ajad.13347] [Reference Citation Analysis]
|
3 |
Greenwald MK, Ghosh S, Winston JR. A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence. Contemp Clin Trials Commun 2022;30:101018. [PMID: 36303593 DOI: 10.1016/j.conctc.2022.101018] [Reference Citation Analysis]
|
4 |
Eaves ER, Trotter RT, Marquez B, Negron K, Doerry E, Mensah D, Compton-gore KA, Lanzetta SA, Kruithoff K, Dykman K, Baldwin JA. Possibilities and constraints of rapid online ethnography: Lessons from a rapid assessment of COVID-19 policy for people who use drugs. Front Sociol 2022;7. [DOI: 10.3389/fsoc.2022.959642] [Reference Citation Analysis]
|